Skip to main content
. 2021 Jun 24;10(13):2770. doi: 10.3390/jcm10132770

Table 1.

Patient characteristics by surveillance adherence group.

Total N Missing N Levels No Surveillance Not Adherent to Surveillance Adherent to Surveillance p
Total N (%) 591 (60.0) 92 (9.3) 302 (30.7)
Age at diagnosis 985 0 Median (25th, 75th centile) 73.0 (64.5 to 79) 67.0 (60.8 to 73) 64.0 (58 to 71) <0.001
Sex 985 0 Female 106 (17.9) 22 (23.9) 68 (22.5) 0.161
Male 485 (82.1) 70 (76.1) 234 (77.5)
Year of diagnosis 985 0 Median (25th, 75th centile) 2012.0 (2011 to 2014) 2012.0 (2011 to 2014) 2013.0 (2011 to 2014) 0.007
Child–Pugh Stage at diagnosis 985 0 No Cirrhosis 142 (24.0) 5 (5.4) 10 (3.3) <0.001
A 169 (28.6) 32 (34.8) 150 (49.7) 0.023
B 209 (35.4) 46 (50.0) 114 (37.7)
C 71 (12.0) 9 (9.8) 28 (9.3)
Alcoholic Liver Disease 985 0 No 331 (56.0) 40 (43.5) 142 (47.0) 0.009
Yes 260 (44.0) 52 (56.5) 160 (53.0)
Viral hepatitis 985 0 No 513 (86.8) 68 (73.9) 194 (64.2) <0.001
Yes 78 (13.2) 24 (26.1) 108 (35.8)
Non-alcoholic fatty liver disease 985 0 No 447 (75.6) 69 (75.0) 236 (78.1) 0.670
Yes 144 (24.4) 23 (25.0) 66 (21.9)
Other 985 0 No 387 (65.5) 69 (75.0) 250 (82.8) <0.001
Yes 204 (34.5) 23 (25.0) 52 (17.2)

All tests are chi-square, except when denoted by † where Kruskal–Wallis tests used. SD—Standard Deviation.